Setting an agenda for comparative effectiveness systematic reviews in CKD care

BMC Nephrology

Correspondence

Raquel C Greer¹  Michael J Choi²  Deidra C Crews³  David Doggett⁴  Kemi A Fawole⁴  Pammie R Crawford⁴  Jodi B Segal⁵  L Ebony Boulware⁶  Jeffrey J Fadrowski⁷ 

[1] Division of General Internal Medicine, Department of Medicine, Baltimore, MD, USA;Division of Nephrology, Department of Medicine, Baltimore, MD, USA;Division of Nephrology, Department of Medicine, Baltimore, MD, USA;Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, MD, USA;Johns Hopkins Bayview Medical Center, 301 Mason F. Lord Drive, Suite 2500, 21224, Baltimore, MD, USA;Johns Hopkins Evidence-based Practice Center, Baltimore, MD, USA;Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, MD, USA;Division of General Internal Medicine, Department of Medicine, Baltimore, MD, USA;Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, MD, USA;Division of General Internal Medicine, Department of Medicine, Baltimore, MD, USA;Department of Epidemiology, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA;Welch Center for Prevention, Epidemiology and Clinical Research, Baltimore, MD, USA;Division of Pediatric Nephrology, Department of Pediatrics, Baltimore, MD, USA;

关键词: Chronic kidney disease;    Evidence-based practice;    Health services research;   

DOI  :  10.1186/1471-2369-13-74

 received in 2012-04-06, accepted in 2012-06-29,  发布年份 2012

来源: Springer

【 摘 要 】

Systematic reviews comparing the effectiveness of strategies to prevent, detect, and treat chronic kidney disease are needed to inform patient care. We engaged stakeholders in the chronic kidney disease community to prioritize topics for future comparative effectiveness research systematic reviews. We developed a preliminary list of suggested topics and stakeholders refined and ranked topics based on their importance. Among 46 topics identified, stakeholders nominated 18 as ‘high’ priority. Most pertained to strategies to slow disease progression, including: (a) treat proteinuria, (b) improve access to care, (c) treat hypertension, (d) use health information technology, and (e) implement dietary strategies. Most (15 of 18) topics had been previously studied with two or more randomized controlled trials, indicating feasibility of rigorous systematic reviews. Chronic kidney disease topics rated by stakeholders as ‘high priority’ are varied in scope and may lead to quality systematic reviews impacting practice and policy.

【 授权许可】

CC BY   
© Crews et al.; licensee BioMed Central Ltd. 2012